Nomura Asset Management CO LTD Argenx Se Transaction History

Nomura Asset Management CO LTD

$37.3 Billion
Q3 2025

A detailed history of Nomura Asset Management CO LTD transactions in Argenx Se stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 13,600 shares of ARGX stock, worth $12.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

13,600

Previous 6,164 120.64%

Holding current value

$12.3 Million

Previous $3.4 Million 195.26%

% of portfolio

0.03%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$538.64 - $768.0 $4.01 Million - $5.71 Million	7,436 Added 120.64%	13,600 $10 Million
Q2 2025 Aug 11, 2025	SELL	$532.27 - $656.65 $782,969 - $965,932	-1,471 Reduced 19.27%	6,164 $3.4 Million
Q1 2025 May 12, 2025	BUY	$571.0 - $671.75 $1.7 Million - $2 Million	2,982 Added 64.09%	7,635 $4.52 Million
Q4 2024 Feb 12, 2025	SELL	$520.52 - $638.33 $1.17 Million - $1.44 Million	-2,254 Reduced 32.63%	4,653 $2.86 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $479,545 - $608,237	-1,347 Reduced 16.32%	6,907 $2.97 Million

Q1 2024 May 13, 2024	SELL	$356.95 - $413.29 $89,594 - $103,735	-251 Reduced 2.95%	8,254 $3.25 Million
Q4 2023 Feb 09, 2024	BUY	$338.91 - $506.01 $126,413 - $188,741	373 Added 4.59%	8,505 $3.24 Million
Q3 2023 Nov 03, 2023	BUY	$369.35 - $548.43 $474,245 - $704,184	1,284 Added 18.75%	8,132 $4 Million
Q1 2022 Jan 10, 2025	SELL	$254.45 - $351.06 $15,012 - $20,712	-59 Reduced 0.85%	6,848 $2.16 Million
Q1 2022 May 13, 2022	BUY	$254.45 - $351.06 $161,066 - $222,220	633 Added 10.19%	6,848 $2.16 Million
Q3 2021 Jan 10, 2025	BUY	$295.0 - $350.58 $193,520 - $229,980	656 Added 11.8%	6,215 $1.88 Million
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $193,520 - $229,980	656 Added 11.8%	6,215 $1.88 Million
Q1 2021 Jan 10, 2025	SELL	$268.3 - $380.31 $361,668 - $512,657	-1,348 Reduced 19.52%	5,559 $1.53 Million
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $1.49 Million - $2.11 Million	5,559 New	5,559 $1.53 Million
Q4 2020 Jan 10, 2025	SELL	$248.13 - $308.36 $1.71 Million - $2.13 Million	-6,907 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$248.13 - $308.36 $0 - $0	0 New	0 $0
Q3 2020 Nov 12, 2020	BUY	$215.51 - $272.51 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$127.44 - $232.72 $0 - $0	0 New	0 $0
Q1 2020 May 14, 2020	BUY	$108.83 - $165.23 $0 - $0	0 New	0 $0
Q4 2019 Feb 13, 2020	BUY	$106.59 - $164.21 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$113.31 - $150.51 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$115.0 - $141.58 $0 - $0	0 New	0 $0
Q1 2019 May 10, 2019	BUY	$98.85 - $134.59 $0 - $0	0 New	0 $0
Q1 2019 May 10, 2019	BUY	$98.85 - $134.59 $0 - $0	0 New	0 $0
Q4 2018 Feb 12, 2019	BUY	$63.81 - $109.82 $0 - $0	0 New	0 $0
Q3 2018 Nov 07, 2018	BUY	$75.5 - $96.63 $0 - $0	0 New	0 $0
Q2 2018 Aug 03, 2018	BUY	$74.84 - $100.16 $0 - $0	0 New	0 $0
Q1 2018 May 14, 2018	BUY	$56.95 - $85.19 $0 - $0	0 New	0 $0
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $0 - $0	0 New	0 $0
Q3 2017 Nov 13, 2017	BUY	$19.81 - $22.61 $0 - $0	0	0 $0

Others Institutions Holding ARGX

# of Institutions

526

Shares Held

26M

Call Options Held

589K

Put Options Held

320K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $50.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Account

Nomura Asset Management CO LTD Argenx Se Transaction History